Corrigendum to "Histamine H1 receptor: a potential therapeutic target for pancreatic ductal adenocarcinoma".
Saved in:
| Title: | Corrigendum to "Histamine H1 receptor: a potential therapeutic target for pancreatic ductal adenocarcinoma". |
|---|---|
| Authors: | Salmerón C; Department of Pharmacology, University of California, San Diego, La Jolla, California., Bort ET; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Sriram K; Department of Pharmacology, University of California, San Diego, La Jolla, California., Javadi-Paydar M; Department of Pharmacology, University of California, San Diego, La Jolla, California., Smitham JE; Department of Pharmacology, University of California, San Diego, La Jolla, California., Pham K; Department of Pharmacology, University of California, San Diego, La Jolla, California., Grose RP; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., McCormick PJ; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., DiNardo A; Department of Dermatology, University of California, San Diego, La Jolla, California., Weitz J; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Tiriac H; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Lowy AM; Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California, San Diego, La Jolla, California., Insel PA; Department of Pharmacology, University of California, San Diego, La Jolla, California. Electronic address: pinsel@health.ucsd.edu. |
| Source: | The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2026 Apr; Vol. 393 (4), pp. 104305. Date of Electronic Publication: 2026 Apr 06. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
